BioWin Cooperation Platform COVID-19
open until December, 31
[Update May, 15]
In the context of the COVID-19 epidemic, BioWin, The Health Cluster of Wallonia, has been widely called upon by its members and the Walloon Government to contribute to the management of the crisis.
To this end, BioWin has set up an interactive platform to gather healthcare initiatives around specific and important themes. These themes are subject to modification and updates according to the positive evolution of the crisis.
This is why the themes have recently evolved.
This platform is open until December, 31. The deadline could be postponed if necessary.
Don’t hesitate to reach the BioWin team members should you have any questions.
Main goals:
- Gather and structure the initiatives around urgent themes,
- Foster interaction between industrial, academic players and other contributors,
- Consolidate critical masses around these themes in order to catalyse and strengthen project development.
Topics addressed:
- Basic research : physiopathology and molecular studies
- Epidemiology and modelisation
- Biobanking
- In vitro & In vivo diagnostic approaches (research & clinical validation)
- In vitro & In vivo diagnostic approaches (industrial production)
- Treatment/Vaccines (research & clinical development)
- Treatment/Drug repurposing (research & clinical development)
- Treatment/Novel therapeutic approaches (research & clinical development)
- Manufacturing of drugs (including biologics and vaccines)
- Medical devices (research & clinical validation)
- e‐health & Digital Applications (research & clinical validation)
- Data science & artificial intelligence
- Manufacturing and recycling of Personal Protection Equipment (masks, disinfectants and sanitizers, ...)
- Behaviour and mental health
- Funding
- Others
We invite you from now on to take an active part on this platform, to choose the theme(s) for which you have a solution or a proposal to share and find a partner with whom to discuss and move towards the realisation.
The entire BioWin team is of course at your service to support you in the search and identification of potential partner(s) and to select the most realistic and impactful initiatives in the current circumstances.
Please take 2 minutes to read the "How it works" section and complete your profile thoroughly. Otherwise the platform will not be successfull.
Contact us
Technical issues: Amélie Moyaerts
Questions regarding the topics?
- Basic research : physiopathology and molecular studies: Thierry Ferain
- Epidemiology and modelisation: Marianne Ghyoot - Thierry Ferain
- Biobanking: Marianne Ghyoot - Joëlle Gahimbare
- In vitro & In vivo diagnostic approaches (research & clinical validation): Sylvie Ponchaut - Thierry Ferain
- In vitro & In vivo diagnostic approaches (industrial production): Sylvie Ponchaut - Thierry Ferain
- Treatment/Vaccines (research & clinical development): Marc Dechamps - Thierry Ferain
- Treatment/Drug repurposing (research & clinical development): Marianne Ghyoot - Thierry Ferain
- Treatment/Novel therapeutic approaches (research & clinical development): Marc Dechamps - Thierry Ferain
- Manufacturing of drugs (including biologics and vaccines): Sylvie Ponchaut - Thierry Ferain
- Medical devices (research & clinical validation): Marianne Ghyoot - Thierry Ferain
- e‐health & Digital Applications (research & clinical validation): Marianne Ghyoot - Joëlle Gahimbare
- Data science & artificial intelligence: Marianne Ghyoot - Sylvie Ponchaut
- Manufacturing and recycling of Personal Protection Equipment (masks, disinfectants and sanitizers, ...): Damien Diop - Joëlle Gahimabre
- Behaviour and mental health: Marianne Ghyoot - Joëlle Gahimbare
- Funding: Olivier Poswick - Damien Diop
Thank you all for your collaboration and commitment.
Sylvie Ponchaut
Managing Director BioWin